Anaphylactoid reaction to alcuronium

Area of Science:

• Anesthesiology
• Immunology
• Cardiology

Background:

• Anaphylaxis during anesthesia poses significant risks.
• Alcuronium is a neuromuscular blocking agent used in anesthesia.
• Cardiovascular collapse is a severe adverse event during anesthetic induction.

Observation:

• A 67-year-old woman experienced sudden cardiovascular collapse during anesthesia induction.
• The event was identified as anaphylaxis caused by alcuronium.
• In vitro testing revealed high specificity to alcuronium with minimal cross-reactivity.

Findings:

• Alcuronium was the causative agent of anaphylaxis.
• The patient demonstrated specific sensitivity to alcuronium.
• The cardiovascular system appears to be the primary target in alcuronium-induced anaphylaxis.

Implications:

• This case highlights the potential for severe anaphylactic reactions to alcuronium.
• Understanding the specific sensitivity and target organ is crucial for patient safety.
• Future anesthetic management can be optimized to mitigate risks associated with alcuronium sensitivity.